Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is a complex condition causing hair loss, linked to genetics and immune system issues, and may be related to other autoimmune diseases; treatments vary in effectiveness.

Sodium valproate caused vomiting, hair loss, loss of appetite, abdominal pain, weight gain, and anemia in young children with epilepsy.

People with autoimmune skin diseases often have hearing problems and should get their hearing checked early.

Interferon and ribavirin can cause serious skin reactions and other health issues.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

CXXC5 is a protein that controls cell growth and healing processes, and changes in its activity can lead to diseases like cancer and hair loss.

Foxp3+ Regulatory T Cells are important for immunity and tolerance, affect hair growth and wound healing, and their dysfunction can contribute to obesity-related diseases and other health issues.

Niosomes are the most effective at delivering drugs to the skin with minimal absorption into the body.

Sex and sex hormones can affect brain inflammation in Parkinson's disease, with male mice being more affected and female mice showing a protective effect.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Alopecia Areata is linked to specific gut bacteria and metabolites, indicating a complex gut microbiome.

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

Ginseng, especially its component ginsenosides, can promote hair growth, reduce hair loss, and potentially treat conditions like alopecia by affecting cell pathways and cytokines.

Wharton’s Jelly stem cells from the umbilical cord improve skin healing and hair growth without scarring.

Light-based treatment, Photobiomodulation, shows promise for non-invasive skin therapy with few side effects.

A man developed excessive hair growth after treatment with interferon-alpha and ribavirin for hepatitis C.

The combination therapy of PEG-IFN α-2a and Ribavirin can cause widespread hair loss and skin reactions.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

A woman's hair loss during treatment with specific hepatitis C drugs grew back after stopping the medication.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

Skin problems like itching, dry skin, and hair loss are more common in hepatitis C patients after interferon treatment, but lichen planus is not linked to the infection.

Alopecia Areata might be linked to Crohn's disease.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.